Agile Therapeutics (AGRX) Market Value Rose While Caxton Raised Stake by $785,780; Comcast New (CMCSA) Shareholder Marble Arch Investments LP Has Trimmed Its Holding by $10.68 Million

January 14, 2018 - By olga

Scott Mclellan decreased its stake in Comcast Corp New (CMCSA) by 15.63% based on its latest 2017Q3 regulatory filing with the SEC. Marble Arch Investments Lp sold 281,000 shares as the company’s stock rose 3.16% with the market. The hedge fund run by Scott Mclellan held 1.52 million shares of the television services company at the end of 2017Q3, valued at $58.37 million, down from 1.80 million at the end of the previous reported quarter. Marble Arch Investments Lp who had been investing in Comcast Corp New for a number of months, seems to be less bullish one the $198.36B market cap company. The stock decreased 0.38% or $0.16 during the last trading session, reaching $42.44. About 18.97 million shares traded. Comcast Corporation (NASDAQ:CMCSA) has risen 28.96% since January 14, 2017 and is uptrending. It has outperformed by 12.26% the S&P500.

Caxton Corp increased its stake in Agile Therapeutics Inc (AGRX) by 12.1% based on its latest 2017Q3 regulatory filing with the SEC. Caxton Corp bought 196,445 shares as the company’s stock rose 35.89% with the market. The institutional investor held 1.82 million shares of the health care company at the end of 2017Q3, valued at $8.12 million, up from 1.62M at the end of the previous reported quarter. Caxton Corp who had been investing in Agile Therapeutics Inc for a number of months, seems to be bullish on the $112.13M market cap company. The stock increased 1.86% or $0.06 during the last trading session, reaching $3.28. About 259,782 shares traded. Agile Therapeutics, Inc. (NASDAQ:AGRX) has declined 48.71% since January 14, 2017 and is downtrending. It has underperformed by 65.41% the S&P500.

Investors sentiment increased to 1.35 in 2017 Q3. Its up 0.74, from 0.61 in 2017Q2. It is positive, as 9 investors sold AGRX shares while 8 reduced holdings. 11 funds opened positions while 12 raised stakes. 23.16 million shares or 7.44% more from 21.56 million shares in 2017Q2 were reported. Jpmorgan Chase & Communication owns 0% invested in Agile Therapeutics, Inc. (NASDAQ:AGRX) for 112,773 shares. United Kingdom-based Barclays Public Limited Co has invested 0% in Agile Therapeutics, Inc. (NASDAQ:AGRX). Geode Limited Liability Corporation reported 171,318 shares. 11,941 are owned by Parametric Port Assocs Lc. Glenmede Tru Na invested in 9,323 shares. Commonwealth Of Pennsylvania Pub School Empls Retrmt reported 0% of its portfolio in Agile Therapeutics, Inc. (NASDAQ:AGRX). Needham Management Ltd Liability Corporation holds 0.57% or 503,538 shares. Deerfield Mngmt has 0.25% invested in Agile Therapeutics, Inc. (NASDAQ:AGRX) for 1.22 million shares. Great Point Prtnrs Ltd Com holds 0.32% or 363,299 shares. Vanguard Grp Incorporated, Pennsylvania-based fund reported 670,032 shares. Investor Ab holds 3.51M shares. Blackrock holds 108,891 shares. Bnp Paribas Arbitrage Sa reported 523 shares or 0% of all its holdings. Bridgeway Capital Incorporated owns 123,000 shares. Renaissance Techs Ltd holds 88,500 shares or 0% of its portfolio.

Among 6 analysts covering Agile Therapeutics (NASDAQ:AGRX), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Agile Therapeutics had 21 analyst reports since December 30, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, December 22 by Cantor Fitzgerald. The stock of Agile Therapeutics, Inc. (NASDAQ:AGRX) earned “Buy” rating by H.C. Wainwright on Thursday, October 12. The stock has “Buy” rating by Noble Financial on Friday, December 22. Cantor Fitzgerald maintained the shares of AGRX in report on Monday, November 20 with “Buy” rating. On Thursday, November 9 the stock rating was maintained by Noble Financial with “Buy”. Cantor Fitzgerald maintained it with “Buy” rating and $8.0 target in Monday, November 6 report. The rating was maintained by H.C. Wainwright with “Buy” on Friday, July 28. The firm earned “Buy” rating on Wednesday, December 30 by Noble Financial. The stock has “Buy” rating by Noble Financial on Monday, June 12. William Blair downgraded the shares of AGRX in report on Friday, December 22 to “Hold” rating.

Since August 7, 2017, it had 0 buys, and 5 sales for $23.18 million activity. Murdock Daniel C. sold $144,915 worth of Comcast Corporation (NASDAQ:CMCSA) on Monday, August 7. On Friday, September 15 BACON KENNETH J sold $83,175 worth of Comcast Corporation (NASDAQ:CMCSA) or 2,232 shares. $22.57 million worth of stock was sold by ROBERTS BRIAN L on Thursday, December 14.

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.02, from 1.01 in 2017Q2. It improved, as 53 investors sold CMCSA shares while 517 reduced holdings. 115 funds opened positions while 470 raised stakes. 3.65 billion shares or 1.23% less from 3.69 billion shares in 2017Q2 were reported. Heritage Wealth Advisors owns 5,691 shares. Sentinel Asset Mgmt, a Vermont-based fund reported 1.41 million shares. Exchange Capital Mngmt Incorporated holds 1.38% of its portfolio in Comcast Corporation (NASDAQ:CMCSA) for 108,860 shares. Huntington Bank stated it has 0.75% of its portfolio in Comcast Corporation (NASDAQ:CMCSA). First Merchants holds 0.25% in Comcast Corporation (NASDAQ:CMCSA) or 37,873 shares. Kings Point Management has invested 0.15% in Comcast Corporation (NASDAQ:CMCSA). Vantage Invest Advsrs Ltd Llc reported 220,774 shares. First Allied Advisory Serv has 49,591 shares. South Dakota Council reported 0.06% stake. First Manhattan reported 1.3% of its portfolio in Comcast Corporation (NASDAQ:CMCSA). Tyrus Sam holds 158,000 shares or 0.48% of its portfolio. The Minnesota-based Pine River Mngmt Ltd Partnership has invested 0.06% in Comcast Corporation (NASDAQ:CMCSA). The California-based Violich Cap Mgmt has invested 0.15% in Comcast Corporation (NASDAQ:CMCSA). Moreover, Keybank Association Oh has 0.41% invested in Comcast Corporation (NASDAQ:CMCSA). Colony Gru Limited Liability holds 140,172 shares or 0.37% of its portfolio.

Among 29 analysts covering Comcast Corporation (NASDAQ:CMCSA), 24 have Buy rating, 1 Sell and 4 Hold. Therefore 83% are positive. Comcast Corporation had 68 analyst reports since July 27, 2015 according to SRatingsIntel. The rating was maintained by Robert W. Baird on Friday, November 17 with “Buy”. The firm has “Buy” rating by Oppenheimer given on Thursday, July 27. The rating was maintained by Goldman Sachs with “Buy” on Wednesday, May 4. The rating was maintained by Guggenheim with “Buy” on Tuesday, December 19. RBC Capital Markets maintained it with “Outperform” rating and $68 target in Wednesday, October 28 report. The stock of Comcast Corporation (NASDAQ:CMCSA) earned “Buy” rating by Wunderlich on Wednesday, August 26. On Monday, October 24 the stock rating was upgraded by Macquarie Research to “Outperform”. The company was initiated on Wednesday, November 11 by SunTrust. RBC Capital Markets maintained Comcast Corporation (NASDAQ:CMCSA) on Thursday, April 28 with “Outperform” rating. The firm has “Neutral” rating given on Tuesday, September 29 by Macquarie Research.

Analysts await Comcast Corporation (NASDAQ:CMCSA) to report earnings on January, 24 before the open. They expect $0.48 EPS, up 9.09% or $0.04 from last year’s $0.44 per share. CMCSA’s profit will be $2.24B for 22.10 P/E if the $0.48 EPS becomes a reality. After $0.52 actual EPS reported by Comcast Corporation for the previous quarter, Wall Street now forecasts -7.69% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>